JMDC saw "control" pass to Omron in February, but JMDC want to grow their health care big data business more aggressively so they are raising money. Looks expensive but index flow is a big mitigant.
SUMMARY
(Sign Up to Access)
Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
Unlock research summaries
Follow top, independent analysts
Receive personalised alerts
Access Analytics, Events and more
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.